-
Adoption of Certara’s proprietary technologies and consulting knowledge aligns with FDA’s commitment to modernizing the drug development process
Jan 22, 2020
-
This transaction broadens the range of specialized services that WCG offers to clinical trial sponsors
Jan 22, 2020
-
Creative Diagnostics launches a large range of p30 antigens and antibodies for ASFV detection.
Jan 16, 2020
-
Jan 18, 2020
-
TriSalusTM Life Sciences, a company committed to transforming outcomes for patients with solid tumors launched its TriNav™ Infusion System.
Jan 14, 2020
-
Thermo Fisher Scientific launches a new high throughput scalable genotyping workflow solution designed for fast-growing labs
Jan 10, 2020
-
Certara’s Simcyp® Simulator’s MechDermA™ model provided safety label claim and pediatric dosing information without the need for testing in clinical patients for a topical drug product.
Jan 7, 2020
-
Jan 4, 2020
-
Dec 18, 2019
-
MR Solutions' 7T PET/MRI preclinical imaging system for nanoparticle imaging shown at the first nanomedicine joint annual meeting in Dijon in December 2019.
Dec 16, 2019
-
New publication combines expert opinions with current news, upcoming events and trending facts
Dec 15, 2019
-
Dec 10, 2019
-
Proscia, a leading provider of AI-enabled digital pathology software, and Johns Hopkins School of Medicine, one of the leading academic medical centers in the U.S., will collaborate on the development of computational applications that incorporate artificial intelligence (AI) to advance the practice of pathology for multiple diseases.
Dec 9, 2019
-
QuantuMDx Group Limited and Ontera, Inc have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection.
Dec 9, 2019
-
Dec 12, 2019
-
Comprehensive service includes project design, specimen selection, library preparation, sequencing and bioinformatics support
Dec 15, 2019
-
MR Solutions has installed the first 7T PET/MR preclinical imaging system in Israel. The dry magnet system is helping to advance medical research at the Wohl Institute for Translational Medicine, part of the Hadassah Hebrew University Medical Center in Jerusalem.
Dec 9, 2019
-
37 leading biopharmaceutical companies now participate in this unique research and development group focused on advancing model-informed drug development
Dec 9, 2019
-
Latest iteration of AIMS (Adjudication Information Management System) has an enhanced user interface to improve efficiency
Dec 9, 2019
-
Proscia, a leading provider of AI-enabled digital pathology software, and the American Cancer Society (ACS) announce a partnership to advance their shared goal of improving patient outcomes through successful treatment. Proscia has formally pledged a portion of its 2020 revenue to the ACS Hope Lodge program, which provides free lodging for patients and their caregivers when the best hope for effective treatment is far from home.* The ACS will help Proscia to raise awareness of the impact of digital pathology among its national network of payers, providers, and advocates.
Dec 4, 2019